🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Human Immunodeficiency Virus Type 1 (HIV-1) Infection

Multi Interventional Approaches to Mitigate HIV Reservoirs for the Sustained HIV Remission Without Antiretrovirals NCT06805656Phase 21 site📍 São Paulo Federal University of São Paulo · Tests: Maraviroc, Dolutegravir, Dendritic Cell Vaccine, Auranofin, Sirtuin Histone deacetylase inhibitor Efficacy and Safety of Doravirine in the Rapid Initiation NCT07357584Phase 42 sites📍 Ciudad Autonoma de Buenos Aire📍 Buenos Aires Fundación Huésped · Tests: Doravirine / lamivudine/ Tenofovir Disoproxil Oral Tablet Analyses of Newly Diagnosed HIV Infection in Hong Kong NCT07725042n/a1 site📍 North Point Chinese University of Hong Kong Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women NCT07616739Phase 410 sites📍 Ciudad Autónoma de Buenos Aires📍 Ciudad Autónoma de Buenos Aires📍 Ciudad Autónoma de Buenos Aires Fundación Huésped · Tests: Dolutegravir/Lamivudine 50 MG-300 MG Oral Tablet [DOVATO], TDF/XTC or TAF/FTC plus Dolutegravir (XTC stand for lamivudi… A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) NCT07202546Phase 2123 sites📍 Bakersfield📍 Palm Springs📍 West Hollywood ViiV Healthcare · Tests: VH4524184, Emtricitabine (FTC) and tenofovir alafenamide (TAF) Fixed Dose Combination (FDC) tablets, Dolutegravir / Lam… Evaluating the Safety and Immunogenicity of MTBVAC NCT05947890Phase 216 sites📍 Johannesburg📍 Westdene📍 Durban HIV Vaccine Trials Network · Tests: MTBVAC, BCG Semaglutide's Efficacy in Achieving Weight Loss for Those With HIV NCT04174755NA1 site📍 Dublin University College Dublin · Tests: Semaglutide Injectable Product, Standard of care Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics NCT05674656Phase 1, Phase 28 sites📍 Long Beach📍 Washington D.C.📍 Fort Lauderdale ViiV Healthcare · Tests: Dolutegravir/Rilpivirine FDC Dolutegravir Plus Lamivudine Simplified Therapy NCT03884673n/a1 site📍 Guangzhou Guangzhou 8th People's Hospital · Tests: DTG+ 3TC Study of Lenacapavir, Teropavimab, and Zinlirvimab in Virologically Suppressed Adults With HIV-1 on Stable Oral Treatment Regimens NCT07683000Phase 32 sites📍 Berkeley📍 Annandale Gilead Sciences · Tests: Lenacapavir, Lenacapavir Tablet, Teropavimab, Zinlirvimab, SBR DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-naïve People Living With HIV-1 Infection NCT06203132Phase 319 sites📍 Nova Iguaçu📍 Rio de Janeiro📍 Yaoundé ANRS, Emerging Infectious Diseases · Tests: Doravirine + tenofovir DF + lamivudine, Dolutegravir + tenofovir DF + lamivudine or emtricitabine Ex Vivo Characterization and Targeting of the Latent HIV Infected Reservoir to Cure HIV NCT05215704n/a1 site📍 Rotterdam Erasmus Medical Center Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants NCT00039689n/a1 site📍 Bethesda National Institute of Allergy and Infectious Diseases (NIAI… Observational PIC Destination Cohort NCT05985642n/a4 sites📍 San Francisco📍 St Louis📍 New York Advancing Clinical Therapeutics Globally for HIV/AIDS and O… Triage Survey for Infectious Disease Eligibility NCT06492187n/a1 site📍 Brooklyn Brooklyn Clinical Research HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label NCT04513626Phase 21 site📍 Paris Centre de Recherches et d'Etude sur la Pathologie Tropicale… · Tests: DORAVIRINE 100 MG [Pifeltro] A Study to Investigate Cabotegravir for Neonates Exposed to HIV-1 NCT07275606Phase 1, Phase 21 site📍 Parow Valley ViiV Healthcare · Tests: Oral CAB, IM CAB LA A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments NCT06337032Phase 415 sites📍 Buenos Aires📍 Panama City📍 Cape Town Gilead Sciences · Tests: F/TAF (High Dose Tablet), F/TAF (Low Dose Tablet), F/TAF (Lowest Dose Tablet), F/TAF (High Dose TOS), F/TAF (Low Dose T… Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066) NCT04375800Phase 224 sites📍 Aurora📍 Atlanta📍 Rionegro Merck Sharp & Dohme LLC · Tests: Doravirine, 2 NRTIs, DOR/3TC/TDF Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France NCT06799338n/a1 site📍 Paris Centre de Recherches et d'Etude sur la Pathologie Tropicale… · Tests: Lenacapavir Injection Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy NCT05187429Phase 1, Phase 22 sites📍 Melbourne📍 Singapore University of Melbourne · Tests: Nivolumab 10 MG/ML [Opdivo], Nivolumab 10 MG/ML [Opdivo], Saline Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children NCT06749054Phase 29 sites📍 Atlanta📍 Cape Town📍 Germiston Gilead Sciences · Tests: Oral Lenacapavir, Subcutaneous Lenacapavir, Optimized Background Regimen (OBR) Efficacy and Safety of ACC017 Tablets Compared With Dolutegravir Sodium Tablets in Treatment-Naïve Adults With Human Immunodeficiency Virus Type 1 (HIV-1) NCT07711223Phase 1, Phase 21 site📍 Beijing Jiangsu Aidea Pharmaceutical Group Co., Ltd. · Tests: ACC017+FTC/TAF, DTG+FTC/TAF Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy NCT07682961Phase 319 sites📍 San Francisco📍 DeLand📍 Fort Lauderdale Gilead Sciences · Tests: Lenacapavir, Lenacapavir Tablet, Teropavimab, Zinlirvimab, Cabotegravir Long-Acting Cabotegravir and Rilpivirine in People Living With HIV-1 Subtype A6: A Real-World Retrospective Study NCT07370649n/a7 sites📍 Prague📍 Frankfurt📍 Szczecin Pomeranian Medical University Szczecin · Tests: Cabotegravir Plus Rilpivirine Long-Acting Injectable Impacts of HIV Treatment Regimens on Archived Drug Resistance NCT07643948n/a1 site📍 Hong Kong Chinese University of Hong Kong Caspofungin for Pneumocystis Pneumonia in PLWHIV. NCT06691321n/a1 site📍 Mexico City Instituto Nacional de Enfermedades Respiratorias Efficacy of Doravirine + Dolutegravir Dual Therapy in the Context of Antiretroviral Therapy Switch NCT04892654Phase 33 sites📍 London📍 London📍 London Chelsea and Westminster NHS Foundation Trust · Tests: Doravirine, Dolutegravir, Triple cART regimen Safety Study of MucoCept-CVN NCT07181486Phase 11 site📍 San Francisco Craig Cohen, MD, MPH · Tests: Live Biotherapeutic Product L. jensenii 1153-1666, Placebo Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption NCT05419024Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Acute Treatment Interruption
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy